Abstract:Objective:To explore the effects of resveratrol (Res) pretreatment on myocardial ischemia reperfusion injury (MIRI) in rats.Methods:Forty-two healthy adult male SD rats were divided into four groups according to random number table method: a sham operation group (Sham group, n=12), a myocardial ischemia reperfusion injury group (IR group, n=12), a resveratrol group (Res group, n=12) and a diltiazem group (positive control group, n=6). Rats in the IR group, the Res group and the positive control group were used to establish a MIRI model through ligating the left anterior descending coronary artery for 30 min followed by reperfusion for 2 h. Rats in the Sham group were threaded without ligation alone. Before establishment of the MIRI model, rats in the Res group and the positive control group were intraperitoneally injected with 20 mg/kg resveratrol and 5 mg/kg diltiazem once per day for seven consecutive days, respectively. Those in the Sham group and the IR group were intraperitoneally injected with an equal volume of dimethyl sulfoxide (DMSO) solution once per day. Abdominal aortic blood samples were collected after reperfusion for 2 h, and the levels of serum lactate dehydrogenase (LDH) and creatine kinase isoenzymes (CK-MB) were measuredby by enzyme-linked immunosorbent assay (ELISA). Myocardial tissue was collected to calculate the percentage of myocardial infarct size, iron content, malondialdehyde (MDA) content and superoxide dismutase (SOD) activity. Western blot was used to detect the levels of glutathione peroxidase 4 (GPX4), ferritin heavy chain (FTH), and fatty acid-coenzyme A ligase 4 (fatty acid-coenzyme A ligase 4, FACL4) in myocardial tissue. Results:Compared with the Sham group: the IR group, Res group and positive control group showed increases in the levels of serum CK-MB and LDH ( P<0.05); IR group and Res group showed increases in the percentage of myocardial infarct size ( P<0.05); IR group showed increases in the iron content, MDA content and FACL4 levels ( P<0.05), and decreases in SOD activity and the levels of FTH and GPX4 in myocardial tissue ( P<0.05). Compared with the IR group: the Res group and positive control group showed significant decreases in the levels of serum CK-MB and LDH ( P<0.005), and decreases in the percentage of myocardial infarct size ( P<0.05); the Res groups presented remarkable decreases in the iron content, MDA content and FACL4 levels in myocardial tissue ( P<0.05), and increases in SOD activity and the levels of FTH and GPX4 ( P<0.05). There was no significant difference in other indexes ( P>0.05). Conclusion:Resveratrol pretreatment can relieve oxidative stress in rat myocardial tissue to inhibit ferroptosis, so as to reduce MIRI.

[Resveratrol Attenuates Hypoxia-Reperfusion Injury Induced Rat Myocardium Microvascular Endothelial Cell Dysfunction Through Upregulating PI3K/Akt/SVV Pathways].

[Resveratrol Protects Against Hydrogen Peroxide Induced Injury in Human Umbilical Vein Endothelial Cells].

Resveratrol Prevents Endothelial Progenitor Cells from Senescence and Reduces the Oxidative Reaction Via PPAR-γ/HO-1 Pathways

Resveratrol Attenuates Myocardial Ischemia/reperfusion Injury Through Up-Regulation of Vascular Endothelial Growth Factor B

[Protection of Hypothermic Preserved Isolated Rat Hearts by Resveratrol and Its Underlying Mechanism].

Protective effect and its mechanism of Resveratrol on hypoxia/reoxygenation-induced apoptosis in cardiac microvascular endothelial cells

Resveratrol attenuates apoptosis of pulmonary microvascular endothelial cells induced by high shear stress and proinflammatory factors

Resveratrol Inhibits Apoptosis of Hypoxia /Reoxygen-Induced Apoptosis of Cardiac Microvascular Endothelial Cells in Rats

Protective Effects of Resveratrol Against Cardiac Microvascular Endothelial Cells Injury Induced by Ischemia-Reperfusion

Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells

Resveratrol exerts protective effects on anoxia/reoxygenation injury in cardiomyocytes via miR-34a/Sirt1 signaling pathway

Resveratrol protects against isoproterenol induced myocardial infarction in rats through VEGF-B/AMPK/eNOS/NO signalling pathway

Resveratrol Inhibits Ischemia-Induced Myocardial Senescence Signals and NLRP3 Inflammasome Activation.

Resveratrol, A Polyphenol Phytoalexin, Protects Cardiomyocytes Against Anoxia/Reoxygenation Injury Via The Tlr4/Nf-Kappa B Signaling Pathway

Protective effect of resveratrol on rat cardiomyocyte H9C2 cells injured by hypoxia/reoxygenation by regulating mitochondrial autophagy PTEN-induced putative kinase protein 1/Parkinson disease protein 2 signaling pathway

Resveratrol protects cardiomyocytes against ischemia/reperfusion-induced ferroptosis via inhibition of the VDAC1/GPX4 pathway

Resveratrol Reestablishes Mitochondrial Quality Control in Myocardial Ischemia/Reperfusion Injury through Sirt1/Sirt3-Mfn2-Parkin-PGC-1 Pathway

Resveratrol, novel application by preconditioning to attenuate myocardial ischemia/reperfusion injury in mice through regulate AMPK pathway and autophagy level

Resveratrol Reestablishes Mitochondrial Quality Control in Myocardial Ischemia/Reperfusion Injury through Sirt1/Sirt3-Mfn2-Parkin-PGC-1α Pathway

Effects of resveratrol pretreatment on myocardial ischemia reperfusion injury

Protective Effect of Resveratrol on Rat Cardiomyocyte H9C2 Cells Injured by Hypoxia/reoxygenation by Regulating Mitochondrial Autophagy Via PTEN-induced Putative Kinase Protein 1/parkinson Disease Protein 2 Signaling Pathway